TSX symbol: BX
TORONTO, Jan. 3, 2017 /CNW/ – BIOX Corporation (“BIOX” or the “Company”) (TSX: BX), a renewable energy company that owns and operates biodiesel production facilities, today announced that it has issued a secured bridge note (the New Bridge Note), in connection with a previously announced new secured bridge note facility, in the amount of US$5,221,546 having a term of three months that bears interest at a rate of 12% per annum, accruing daily and compounding monthly. All accrued and unpaid interest under the New Bridge Note will be payable on March 31, 2017.
The New Bridge Note was issued January 1, 2017 and replaces the US$5,000,000 secured bridge note issued by BIOX in June 2016 concurrent with BIOX’s investment in the World Energy BIOX Biofuels LLC joint venture, which acquired a 90 million U.S. gallon nameplate capacity biodiesel facility in Houston, Texas.
About BIOX Corporation
BIOX is a renewable energy company that owns 287.5 million litres of nameplate biodiesel production capacity at plants located in southern Ontario and Houston, Texas. BIOX has an innovative, proprietary and patented production process that is capable of producing the highest quality, renewable, clean burning and biodegradable biodiesel fuel utilizing a variety of feedstocks – from pure seed oils to animal fats to recovered vegetable oils with no change to the production process. BIOX’s high quality biodiesel fuel meets North American (ASTM D-6751) quality standards.
Certain statements in this press release constitute “forward-looking” statements that involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance, objectives or achievements of BIOX, or industry results, to be materially different from any future results, performance, objectives or achievements expressed or implied by such forward-looking statements. These statements reflect BIOX’s current views regarding future events and operating performance, are based on information currently available to BIOX, and speak only as of the date of this press release. These forward-looking statements involve a number of risks, uncertainties and assumptions and should not be read as guarantees of future performance or results, and will not necessarily be accurate indications of whether or not such performance or results will be achieved. Those assumptions and risks include, but are not limited to, the fact that BIOX’s results of operations and business outlook are highly dependent on a mix of legislation and producer payment programs and tax credits and upon commodity prices, which are subject to significant volatility and uncertainty. Many factors could cause the actual results, performance or achievements of BIOX to be materially different from any future results, performance or achievements that may be expressed or implied by such forward-looking statements, including factors described in this press release and those discussed in BIOX’s publicly available disclosure documents, as filed by BIOX on SEDAR (www.sedar.com) except as updated herein. Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward-looking statements prove incorrect, actual results may vary materially from those described in this press release as intended, planned, anticipated, believed, estimated or expected. Unless required by applicable securities law, BIOX does not intend and does not assume any obligation to update these forward-looking statements. To the extent any forward-looking statements herein constitute financial outlook, they were approved by management as of the date hereof and have been included to provide an understanding with respect to BIOX’s financial performance and are subject to the same risks and assumptions referred to herein. There can be no assurance that the plans, intentions or expectations upon which these forward-looking statements are based will occur and readers are cautioned that any financial outlook information contained in this news release should not be used for purposes other than for which it is disclosed herein.
SOURCE BIOX Corporation